Galleri Blood Test Shows Promise in Detecting 50 Types of Cancer in Large Clinical Trial
The Galleri test looks for fragments of DNA that have broken off a tumour and are circulating in the blood.
Read the full articleYou might also wanna read
The NHS-Galleri trial: What to expect in 2026 from the world’s first randomized controlled trial of a Multi-Cancer Early Detection test, Galleri®
As the multi-cancer early detection (MCED) field evolves, we and others have asserted that it is essential – in order for individuals to hav
PATHFINDER 2: What to Expect from the Largest U.S. Multi-Cancer Early Detection (MCED) Interventional Trial
Cancer screening has transformed outcomes for several cancers, but the vast majority of cancer deaths still occur in patients who have cance
GRAIL Update on the Accelerated Implementation of Multi-Cancer Early Detection Technology by NHS England
The NHS-Galleri trial, which started enrolling participants in 2021, was designed to inform implementation of the Galleri test as a national
AI method using multiple DNA fragment clues improves blood-based cancer detection, study finds
Researchers have developed an artificial intelligence method that can detect signs of cancer by combining several different clues found in D
bci.qmul.ac.uk·3d agoCanadian trial to test blood-based cancer detection in 7,000 survivors
SHERLOCK will recruit patients who have already undergone treatments intended to cure their disease The post Canadian trial to test blood-ba
Can a blood test tell patients if their cancer is coming back? Researchers are on it
Researchers at Princess Margaret Cancer Centre in Toronto are working on a large trial to determine if a blood test can detect tiny amounts
Comments
Sign in to join the conversation.
No comments yet. Be the first.